Back
Scribe Therapeutics Inc. SCTX · Transcripts
website
Scribe Therapeutics is a clinical-stage biotechnology company focused on developing in vivo CRISPR-b...82
Price16.68
Market Cap254.06 M
Float1.7 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
Search in Documents